- Home
- NMIH vs GPCR Comparison
NMIH vs GPCR Comparison
Compare NMIH & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | NMIH | GPCR |
|---|---|---|
| Founded | 2011 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.8B |
| IPO Year | 2013 | 2023 |
Fundamental Metrics
Financial Performance| Metric | NMIH | GPCR |
|---|---|---|
| Price | $40.56 | $33.67 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 12 |
| Target Price | $43.25 | ★ $103.17 |
| AVG Volume (30 Days) | 452.3K | ★ 899.5K |
| Earning Date | 04-30-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 11.06 | N/A |
| EPS | ★ 2.66 | N/A |
| Revenue | ★ $706,440,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.34 | N/A |
| P/E Ratio | $15.23 | ★ N/A |
| Revenue Growth | ★ 8.52 | N/A |
| 52 Week Low | $34.84 | $25.59 |
| 52 Week High | $46.74 | $94.90 |
Technical Indicators
Market Signals| Indicator | NMIH | GPCR |
|---|---|---|
| Relative Strength Index (RSI) | 21.16 | 25.37 |
| Support Level | $36.12 | N/A |
| Resistance Level | $42.15 | $56.63 |
| Average True Range (ATR) | 0.94 | 1.77 |
| MACD | -0.34 | -0.08 |
| Stochastic Oscillator | 0.24 | 1.52 |
Price Performance
Historical ComparisonAbout NMIH NMI Holdings Inc.
NMI Holdings Inc through its subsidiaries provides private mortgage guaranty insurance. The company offers mortgage insurance, reinsurance on loans, and outsourced loan review services to mortgage loan originators. It serves national and regional mortgage banks, money center banks, credit unions, community banks, builder-owned mortgage lenders, Internet-sourced lenders, and other non-bank lenders. It protects lenders and investors from default-related losses on a portion of the unpaid principal balance of a covered mortgage.
About GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.